Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,585 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06464861RecruitingPhase 1
Sequential CD19 CAR-NK and CAR-T for B-cell lymphoma
This trial tests a new combination treatment: first, natural killer cells (NK cells) that are engineered to find CD19, followed by CAR-T cells (also targeting CD19). It is for people with B-cell lymphoma that has come back or not responded to standard treatments.
Hangzhou, ZhejiangAges 18–75 - NCT06464679RecruitingPhase 1
CD19 CAR NK cells for autoimmune diseases
This trial tests a new type of immune cell therapy (CD19 CAR NK cells) for people with certain autoimmune diseases that have not responded to standard treatments. The goal is to see if these cells can safely reduce disease activity.
ShanghaiAges 18–65 - NCT06464744Recruiting
Can brain stimulation help after spinal cord injury?
This trial tests whether repetitive transcranial magnetic stimulation (rTMS), a non-invasive treatment that uses magnetic pulses to stimulate the brain, can improve movement and function in people with chronic spinal cord injury. It may help if you have some movement left below your injury level.
OsloAges 18–80 - NCT06465433RecruitingPhase 2
Continued Tafasitamab Treatment for Blood Cancer
This trial allows people with blood cancers who are already benefiting from tafasitamab treatment in another study to keep receiving it. It helps ensure you can continue this therapy without interruption.
GyőrAges 18–99 - NCT06466031Recruiting
PET/MRI for guiding glioblastoma surgery
This trial tests whether a special PET scan combined with MRI can help guide surgery for glioblastoma. It is for people with a newly diagnosed, single tumor who are candidates for surgery.
Lodz, Łódź VoivodeshipAges 18–70 - NCT06466122RecruitingPhase 2
Pirtobrutinib plus Venetoclax for resistant CLL or SLL
This trial tests two oral targeted drugs—pirtobrutinib and venetoclax—for people with CLL or SLL whose disease has continued to grow despite taking a BTK inhibitor (such as ibrutinib, acalabrutinib, or zanubrutinib). The goal is to see if this combination can control the cancer when a BTK inhibitor alone is no longer working.
Columbus, OhioAges 18 years+ - NCT06466330Recruiting
Knee embolization for post-replacement pain
This trial tests a non-surgical treatment called microparticle geniculate artery embolization for people with persistent knee pain after a total knee replacement. It aims to reduce pain by blocking tiny blood vessels that may be causing inflammation.
CréteilAges 40–80 - NCT06466382Recruiting
Personalized therapy for advanced ovarian cancer
This study tests a personalized cancer therapy designed just for you and your tumor. It is for people with newly diagnosed advanced ovarian cancer who can wait a short time before starting treatment and plan to have surgery after 2 cycles of chemotherapy.
Baden, Canton of AargauAges 18 years+ - NCT06466356Recruiting
Learning to prevent suicide after a crisis
This trial tests a short educational program to help people who have had a suicide attempt or serious suicidal thoughts. The goal is to reduce future risk by teaching coping skills and support strategies.
Levanger, TrøndelagAges 18–99 - NCT06467617RecruitingPhase 2
Immunotherapy and chemo before and after lung cancer surgery
This trial tests a combination of an immunotherapy drug (adebrelimab) plus chemotherapy and another drug (recaticimab) before and after surgery for people with stage II or III lung cancer that can be removed. The goal is to see if this approach helps shrink tumors and improves outcomes.
Beijing, Beijing MunicipalityAges 18–75 - NCT06467916Recruiting
PATH program for NICU parent mental health
This study is creating a program called PATH to help NICU parents with their mental health during the stressful time of leaving the hospital and going home. It aims to find out what support parents need most and how to provide it.
Aurora, ColoradoAges Any age - NCT06468124Recruiting
Testing treatments on mini tumors for breast cancer that has spread
This trial uses a special lab technique (called organoids) to grow a mini version of your tumor from a biopsy sample. Researchers will test different treatments on these mini-tumors to see which one might work best for you.
LondonAges 18 years+ - NCT06469281RecruitingPhase 1
A new immune cell therapy for recurring ovarian cancer
This early-phase trial tests a new immune cell therapy called 27T51, which targets a protein called MUC16 found on ovarian cancer cells. The study is for people with recurrent or treatment-resistant ovarian, primary peritoneal, or fallopian tube cancer to see if the therapy is safe and works when given alone or with other treatments.
Boston, MassachusettsAges 18 years+ - NCT06469190RecruitingEarly Phase 1
CAR NK cells for treatment-resistant kidney disease
This trial is testing a new therapy made from your own immune cells (called CAR NK cells) that are designed to fight a type of kidney disease that hasn't responded to standard treatments. It may be an option if you have membranous nephropathy, IgA nephropathy, or ANCA-associated vasculitis and previous treatments have failed.
ShanghaiAges 18–70 - NCT06469437Recruiting
Geriatric check for older adults with type 2 diabetes
This study looks at how a full health check for older adults with type 2 diabetes can help doctors choose the best treatment plan. It aims to improve care for people 60 and older.
Porto Alegre, Rio Grande do SulAges 60 years+ - NCT06470698Recruiting
Using emotional awareness to predict treatment success in addiction
This trial tests whether tracking emotional awareness can help predict how well people recover from cocaine or alcohol addiction. It uses a mobile app to monitor feelings and progress.
HuelvaAges 18 years+ - NCT06471166Recruiting
Treating Tubal Ectopic Pregnancy and Ovarian Reserve
This study looks at different ways to treat tubal ectopic pregnancy to see how they might affect your future fertility (ovarian reserve). It helps doctors understand which treatment is best for preserving egg supply.
AsyutAges 18–44 - NCT06471452Recruiting
Living Better After Breast Cancer Treatment
This study is for people who have completed breast cancer treatment and want to improve their quality of life. It tests ways to help you feel better and live well after treatment.
StockholmAges 18 years+ - NCT06472063Recruiting
Surgery first vs chemo then surgery for advanced stomach cancer
This trial compares two approaches for stomach cancer that has spread a bit but can still be removed with surgery. One group has surgery first, the other gets chemotherapy before surgery. The goal is to see which sequence leads to better long-term outcomes.
Orbassano, PiedmontAges 18 years+ - NCT06472583RecruitingPhase 2
Immunotherapy and radiation before breast cancer surgery
This trial tests giving immunotherapy combined with a precise, high-dose radiation boost before surgery for HER2-negative breast cancer. The goal is to see if this approach can improve outcomes, especially for cancers that are more advanced or have spread to a few other spots in the body.
GliwiceAges 18 years+ - NCT06472934Recruiting
Beta-blockers & TAVR study
This study tests whether continuing a beta-blocker (a heart medication) improves outcomes for people having a planned TAVR (a minimally invasive heart-valve replacement). It may help doctors decide whether to keep or stop this medicine after the procedure.
GrazAges 18 years+ - NCT06473623Recruiting
Ear-based nerve stimulation for autism
This trial tests a new, non-invasive way to stimulate the vagus nerve using a gentle device on the ear. The goal is to see if it can help improve social and communication symptoms in children and young adults with autism.
Tai PoAges 7–26 - NCT06474689Recruiting
EMDR vs. CBT for obese women with binge eating
This trial tests two therapy approaches – EMDR and CBT – to see which works better for women with both obesity and binge eating disorder who are already staying in an Italian hospital. The study focuses on how these treatments may help with eating behaviors and emotional healing.
Piancavallo, VerbaniaAges 18–65 - NCT06474884Recruiting
Single blood thinner after shielded stent for brain aneurysm
This study is testing whether using only one blood-thinning medication (single antiplatelet therapy) after placing a special stent (Pipeline Flex with Shield) is safe and effective for treating unruptured brain aneurysms. It is for people who have already been on two blood thinners for a few days before the stent placement.
BeijingAges 18–80
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,585 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.